AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03127514 · COMPLETED

Trial details

NCT number: NCT03127514
Sponsor: Amylyx Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis Motor Neuron Disease Neuromuscular Diseases Neurodegenerative Diseases Spinal Cord Diseases TDP-43 Proteinopathies Nervous System Diseases Central Nervous System Diseases

Start date: 2017-06-22
Primary completion: 2019-09-25
Enrollment: 137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.